Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 2

1(33.3%)

3Total

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04109053Withdrawn

Ultrasensitive Electroanatomic Mapping to Adjudicate Endpoints for Ablation In Paroxysmal AF Patients Using Cryoballoon

Role: lead

NCT07197957Recruiting

Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury

Role: lead

NCT07196306Phase 2Withdrawn

Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19

Role: lead

NCT05893420Not ApplicableActive Not Recruiting

A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning

Role: collaborator

NCT03862222Completed

Atlas of Retinal Imaging in Alzheimer's Study

Role: collaborator

NCT06591182Enrolling By Invitation

Effects of Social Determinants of Health on IV Iron Treatments

Role: lead

NCT06152016Not ApplicableCompleted

BE FAST vs. FAST: A Study in the General Public.

Role: collaborator

All 7 trials loaded